company background image
ATAN

Attana NGM:ATANA Stock Report

Last Price

kr0.62

Market Cap

kr133.3m

7D

4.5%

1Y

-56.2%

Updated

15 Aug, 2022

Data

Company Financials +
ATANA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

ATANA Stock Overview

Attana AB provides biologically related information to customers in developing pharmaceutical drugs primarily in Europe and Asia.

Attana AB Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Attana
Historical stock prices
Current Share Pricekr0.62
52 Week Highkr0
52 Week Lowkr0
Beta1.16
1 Month Change-1.74%
3 Month Change-16.04%
1 Year Change-56.19%
3 Year Change27.14%
5 Year Changen/a
Change since IPO62.24%

Recent News & Updates

Shareholder Returns

ATANASE Life SciencesSE Market
7D4.5%2.1%0.9%
1Y-56.2%-52.4%-20.9%

Return vs Industry: ATANA underperformed the Swedish Life Sciences industry which returned -52% over the past year.

Return vs Market: ATANA underperformed the Swedish Market which returned -21.8% over the past year.

Price Volatility

Is ATANA's price volatile compared to industry and market?
ATANA volatility
ATANA Average Weekly Movement8.1%
Life Sciences Industry Average Movement7.9%
Market Average Movement7.2%
10% most volatile stocks in SE Market12.6%
10% least volatile stocks in SE Market4.5%

Stable Share Price: ATANA is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: ATANA's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20029Teodor Aastruphttps://www.attana.com

Attana AB provides biologically related information to customers in developing pharmaceutical drugs primarily in Europe and Asia. The company offers analytical biosensor instruments for automated analysis of molecular interactions with cells and tissues; and contract research services. It serves academic institutions, biotech companies, and pharma companies.

Attana AB Fundamentals Summary

How do Attana's earnings and revenue compare to its market cap?
ATANA fundamental statistics
Market Capkr133.33m
Earnings (TTM)-kr16.69m
Revenue (TTM)kr8.59m

14.9x

P/S Ratio

-7.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ATANA income statement (TTM)
Revenuekr8.59m
Cost of Revenuekr1.54m
Gross Profitkr7.05m
Other Expenseskr23.74m
Earnings-kr16.69m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.081
Gross Margin82.07%
Net Profit Margin-194.21%
Debt/Equity Ratio7.2%

How did ATANA perform over the long term?

See historical performance and comparison